October 14, 2026
Oculis Outlines Genotype-Based Dry Eye Strategy
The phase 3 PREDICT-1 trial is evaluating licaminlimab in patients with dry eye disease, with a primary analysis focused on a genetically defined subgroup.
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/dydjvcpi/adobestock_526526544.jpg
Ophthalmology Management
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/a1lfxny5/rp1026_aao_digital_cover_v1.jpg
Retinal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/0eypbm5l/0926_fc_gp.jpg
Glaucoma Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/0jsmmz3o/op_1025_cover_final.jpg
Ophthalmic Professional
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/tmzkk4zx/1026_oasc_cover_large.jpg
The Ophthalmic ASC
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/aqbjxwjw/pp-cover.jpg
Presbyopia Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/npjdtl1w/cp_november_cover.jpg
Corneal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/mvqdq2hc/nrp_cover_october_2024.jpg
New Retinal Physician
October 14, 2026
The phase 3 PREDICT-1 trial is evaluating licaminlimab in patients with dry eye disease, with a primary analysis focused on a genetically defined subgroup.
October 13, 2026
Practical strategies for strengthening ophthalmology practice budgets and alleviating financial pressure.
October 13, 2026
Secondary IOL placement techniques and key considerations for selecting the most appropriate approach for patients with dislocated lenses.
October 13, 2026
Remigromig demonstrated noninferiority in mean change from baseline in BCVA vs ranibizumab at 1 year in patients with diabetic macular edema.
October 13, 2026
Ophthalmologists share real-world experiences using AI to streamline cataract consultations, support postoperative monitoring, and enhance patient care while maintaining physician oversight.
October 12, 2026
How practices can boost revenue cycle health using essential KPIs.
October 12, 2026
From retinal toxicity to cataract surgery complications, systemic medications can reveal important clinical risks that technicians can help identify.
October 12, 2026
Alexandra Acabá Berrocal, DHA, FACMPE, MSW, discusses her recent AAO 2026 workshop, “Sustainable Growth for Small Practices: Designing Performance-Driven Incentive Plans”
October 12, 2026
Clinicians can systematically identify the source of postoperative cataract dissatisfaction in patients.
October 12, 2026
Soosan Jacob, MS, FRCS, DNB, MNAMS, explains what was covered in her recent AAO 2026 instruction course, “Transitioning to CAIRS.”
October 12, 2026
Phase 1/2 findings presented at AAO 2026 show high rates of medication independence and comparable safety outcomes following cataract surgery.
October 12, 2026
The resource offers current research, clinical insights, and practical strategies to incorporate ocular surface care into existing workflows.
October 11, 2026
Clinical evidence, practical considerations, and sustainability benefits of dropless cataract surgery as an alternative to traditional postoperative eye-drop regimens.
October 11, 2026
Strategies for maintaining practice independence through succession planning, physician partnerships, new revenue opportunities, and sustainable growth without private equity.
October 11, 2026
How practices can approach AI adoption strategically, with careful consideration of vendor contracts, data use, intellectual property, and long-term commitments.
October 11, 2026
Practical techniques to help ophthalmologists individualize glaucoma treatment and incorporate interventional approaches into everyday practice.
October 11, 2026
Experts provide steps for using this ophthalmic lens to determine both cylinder axis and power.
October 11, 2026
Exploring real-world applications of AI to streamline operations, improve staff training, and increase efficiency while emphasizing the importance of human oversight.
October 11, 2026
New data from a European trial suggest that vision restored by a chip placed beneath the retina can last.
October 9, 2026
A study examined emergency room visits over a 20-year period and found that the risks shift with age.
Affiliations:
Specialties:
Areas of Expertise: